Heterocyclic compounds as TYK2 inhibitors, their synthesis, and applications

JP7943954B2Active Publication Date: 2026-10-30ZHEJIANG WENDA PHARMA TECH LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2025522045
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2023-08-28
Filing Date
2024-04-17
Publication Date
2026-10-30
Estimated Expiration
2044-04-17

Smart Images

  • Figure 0007943954000069
    Figure 0007943954000069
  • Figure 0007943954000070
    Figure 0007943954000070
  • Figure 0007943954000071
    Figure 0007943954000071
Patent Text Reader

Abstract

The present invention provides heterocyclic compounds as TYK2 inhibitors, and their synthesis and application. Specifically, the present invention provides a compound or a pharmaceutically acceptable salt thereof, wherein the compound is as shown in formula (A), and each group is as defined herein. [Formula 1] TIFF2025534771000074.tif61170
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Substituted heterocyclic compounds

    WO2022241171A1

  • Substituted heterocyclic compounds

    WO2022241173A1

  • Substituted heterocyclic compounds

    WO2022241174A1

  • Compound as TYK2 / JAK1 pseudokinase domain inhibitor, and synthesis and use methods

    WO2023030335A1